NO996132L - Vaccine compositions comprising Heliobacter pylori FlgE polypeptide - Google Patents

Vaccine compositions comprising Heliobacter pylori FlgE polypeptide

Info

Publication number
NO996132L
NO996132L NO996132A NO996132A NO996132L NO 996132 L NO996132 L NO 996132L NO 996132 A NO996132 A NO 996132A NO 996132 A NO996132 A NO 996132A NO 996132 L NO996132 L NO 996132L
Authority
NO
Norway
Prior art keywords
vaccine compositions
heliobacter pylori
flge polypeptide
helicobacter pylori
pylori flge
Prior art date
Application number
NO996132A
Other languages
Norwegian (no)
Other versions
NO996132D0 (en
Inventor
Thomas Berglindh
Bjoern Mellgord
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996132D0 publication Critical patent/NO996132D0/en
Publication of NO996132L publication Critical patent/NO996132L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Abstract

Heliobacter pylori FlgE-polypeptid Foreliggende oppfinnelse vedrører polypeptider og vaksinesammcnsetninger for indu- sering av en beskyttende immunrespons mot Helicobakter pylori-infcksjon. Oppfinnel- sen vedrører videre anvendelse av Helicobacterpylori-po\ypepMer i fremstillingen av sammensetninger for behandling eller profylakse av Helicobfictcrpylori-mfeksjon.The present invention relates to polypeptides and vaccine compositions for inducing a protective immune response against Helicobacter pylori infection. The invention further relates to the use of Helicobacter pylori polyps in the preparation of compositions for the treatment or prophylaxis of Helicobacter pylori infection.

NO996132A 1997-06-12 1999-12-10 Vaccine compositions comprising Heliobacter pylori FlgE polypeptide NO996132L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (en) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (2)

Publication Number Publication Date
NO996132D0 NO996132D0 (en) 1999-12-10
NO996132L true NO996132L (en) 2000-01-28

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996132A NO996132L (en) 1997-06-12 1999-12-10 Vaccine compositions comprising Heliobacter pylori FlgE polypeptide

Country Status (21)

Country Link
EP (1) EP1009764A1 (en)
JP (1) JP2002507118A (en)
KR (1) KR20010013699A (en)
CN (1) CN1259960A (en)
AR (1) AR012896A1 (en)
AU (1) AU8048798A (en)
BR (1) BR9810026A (en)
CA (1) CA2293293A1 (en)
EE (1) EE9900566A (en)
HU (1) HUP0003164A3 (en)
ID (1) ID23052A (en)
IL (1) IL133144A0 (en)
IS (1) IS5288A (en)
NO (1) NO996132L (en)
NZ (1) NZ501427A (en)
PL (1) PL337503A1 (en)
SE (1) SE9702242D0 (en)
SK (1) SK173099A3 (en)
TR (1) TR199903060T2 (en)
WO (1) WO1998056816A1 (en)
ZA (1) ZA984696B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (en) * 2015-04-27 2015-07-22 苏州大学附属第一医院 Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa
CN113425717B (en) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof
CN116535472B (en) * 2023-05-31 2024-04-30 四川大学华西医院 Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE

Also Published As

Publication number Publication date
WO1998056816A1 (en) 1998-12-17
BR9810026A (en) 2000-09-19
ID23052A (en) 2000-01-20
AU8048798A (en) 1998-12-30
IS5288A (en) 1999-12-08
EE9900566A (en) 2000-06-15
PL337503A1 (en) 2000-08-28
SE9702242D0 (en) 1997-06-12
AR012896A1 (en) 2000-11-22
HUP0003164A2 (en) 2000-12-28
TR199903060T2 (en) 2000-09-21
CA2293293A1 (en) 1998-12-17
IL133144A0 (en) 2001-03-19
KR20010013699A (en) 2001-02-26
HUP0003164A3 (en) 2001-10-29
ZA984696B (en) 1999-01-04
NZ501427A (en) 2000-09-29
EP1009764A1 (en) 2000-06-21
CN1259960A (en) 2000-07-12
SK173099A3 (en) 2000-06-12
JP2002507118A (en) 2002-03-05
NO996132D0 (en) 1999-12-10

Similar Documents

Publication Publication Date Title
GB2303854B (en) Helicobacter proteins and vaccines
NO975490D0 (en) Heliobacter pylori antigens and vaccine compositions
DK264782A (en) PEPTIDES THAT AFFECT IMMUNE REGULATION AND PROCEDURE FOR THEIR PREPARATION
HK1037639A1 (en) Particles of hcv envelope proteins: use for vaccination hcv.
DK1095061T3 (en) Peptides based on the sequence of human lactoferring and their use
HUP9801266A2 (en) Multimeric, recombinant urease vaccine
NO893196D0 (en) HYBRID-PROTEIN-C COMPOSITIONS AND PROCEDURES FOR THEIR PREPARATION.
NO991995L (en) Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof
DK366783A (en) PROCEDURE FOR PREPARING A POLYPEPTIDE WITH IMPACT ON THE IMMUNE SYSTEM
NO996132L (en) Vaccine compositions comprising Heliobacter pylori FlgE polypeptide
DE3773295D1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HK1006674A1 (en) Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
NO963892L (en) Use of dimeticone for local antibacterial therapy and / or obstruction and therapy in connection with Helicobacter pylori (HP) associated syndromes and infectious diseases
FR2676068B1 (en) IMMUNOGENIC RECOMBINANT STRAINS OF B. ANTHRACIS - IMMUNOGENIC COMPOSITIONS CONTAINING THEM.
AR010568A1 (en) POLYPEPTIDE, VACCINE COMPOSITION, USE OF POLYPEPTIDE IN THE MANUFACTURE OF A COMPOSITION, AND METHOD TO PRODUCE AN IMMUNO-PROTECTIVE RESPONSE AGAINST HELICOBACTER PYLORI INFECTION
SE9702240D0 (en) Vaccine compositions III
DK0952771T3 (en) New Saponin Preparations and Uses thereof
SE9702241D0 (en) Vaccine compositions IV
NO830144L (en) HYDROLYZED WHEAT OR HYDROLYZED WHEAT FRACTION AS EMULSANT, PROCEDURE FOR PREPARING THEREOF, AND USE AS FOOD DRESS
NO20011075D0 (en) Peptide fragments of cholera toxin or enterotoxin as vaccine adjuvants
NO930401D0 (en) PEPTIDES BLOCKING HIV INFECTIONS AND METHODS OF USING IT
SE9901548D0 (en) Helicobacter pylori antigens
IT1276453B1 (en) HELYCOBACTER PYLORI VACCINE/THERAPEUTIC COMPOSITIONS, THEIR PREPARATION AND USE.
NO872151D0 (en) CRYSTALLINIC, AMINO PROTECTED AMINO ACIDS AND PROCEDURE FOR THEIR PREPARATION.
DK565285A (en) PEPTID VACCINE OR DIAGNOSTIC AGENT AND POLYPEPTIDE FOR USE THEREOF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application